Authors : Dr. J.G. Bhatt; Dr. J.G.Vagadia; Dr. Manisha Nakum; Dr. Binoy Kumar

Volume/Issue : Volume 10 - 2025, Issue 7 - July

Google Scholar : https://tinyurl.com/yubn44mb

Scribd : https://tinyurl.com/39tvn9cj

DOI : https://doi.org/10.38124/ijisrt/25jul1289

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Introduction Gastrointestinal stromal tumors (GISTs) are the most frequent malignant mesenchymal lesions of the gastrointestinal tract believed to originating from the interstitial cells of Cajal. These tumors typically exhibits overexpression of the tyrosine kinase receptor, protein product of c‐KIT gene (KIT) CD 117.they may appear in GI tract and most frequently found in the stomach(60%) .  Objective: To analyze the clinical characteristics , diagnosis , treatment , approaches, recurrence, and survival rates of GISTS. In this case, series a total number of 3 patients, admitted and operated in the surgical department of PDU Medical College and Hospital .The age range of the patients was 50 to 70years. The cases were evaluated for symptoms ,tumor location ,size,diagnostic findings , surgical approach and outcomes. Out of 3 cases, 2 occurred in the stomach, 1 in jejunum.  Conclusion: GISTs are aggressive tumors, particularly when located in stomach . Diagnosis and treatment strategies depend on their size and location, surgical intervention remains the mainstay of treatment , with endoscopy playing a role in selected cases.

Keywords : GISTS, Diagnosis, Differential Diagnosis, Management, Localization Histopathology.

References :

1. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002;10(2):81-9.
2. Rubin JL, Sanon M, Taylor DC, Coombs J, Bollu V, Sirulnik L. Epidemiology, survival, and costs of localized gastrointestinal stromal tumors. Int J Gen Med.2011;4:121-30
3. Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol. 2001;25(9):1121-33.
4. Miettinen M, Kopczynski J, Makhlouf HR, SarlomoRikala M, Gyorffy H, Burke A, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol. 2003;27(5):625-41.
5. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24(2):211-22.
6. Wente MN, Büchler MW, Weitz J. Gastrointestinale Stromatumoren (GIST). Chirurgische Therapie. Chirurg. 2008;79(7):638-43. https://doi.org/10.1007/s00104-008-1527-5
7. Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382(9896):973-83. https://doi.org/10.1016/S0140-6736(13)60106-3
8. McDonnell MJ, Punnoose S, Viswanath YKS, Wadd NJ, Dhar A. Gastrointestinal stromal tumours (GISTs): an insight into clinical practice with review of literature. Frontline Gastroenterol. 2017;8(1):19-25. https://doi.org/10.1136/flgastro-2015-100670
9. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohisto chemical and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52- 68. https://doi.org/10.1097/01.pas.0000146010.92933.de
10. Yacob M, Inian S, Sudhakar CB. Gastrointestinal Stromal Tumours: Review of 150 Cases from a Single Centre. Indian J Surg. 2015; 77(Suppl 2):505-10. https://doi.org/10.1007/s12262-013-0899-z